Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age50+
SponsorBeni-Suef University
About this trial
COPD represents an important public health challenge that is both preventable and treatable. GOLD is committed to improving the health of people at risk of and with COPD, wherever they happen to have been born, and wishes to do its bit to help achieve the United Nations Sustainable Development Goal to reduce premature mortality from non-communicable diseases - including COPD - by one third by 2030. GOLD aims in stable COPD to relieve symptoms, improve exercise tolerance and improve health status. Non-pharmacological interventions for those high-risk groups of patients, studies of intervention strategies both during inpatient stay and shortly after discharge have been undertaken, to decrease readmission rates and improve QOL, including disease-specific self-management, pulmonary rehabilitation, and early medical follow-up.Seeking for allow cost way to alleviate patients' symptoms in order to increase independence and QOL.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Only females diagnosed with a history of using biomass fuel for cooking and heating during their lifetime with no history of smoking or being Ex smoker nor a non-smoker.
Participants in clear consciousness.
participants diagnosed with shortness of breath or dyspnea that was not caused by heart disease, pneumothorax, or pulmonary oedema
Disqualifiers
Systolic blood pressure lower than 90 mmHg.
Participants with unstable psychological status, hemoptysis, pneumothorax, pulmonary edema.
Trial design
Design model
Parallel
Treatments tested in this trial
Intervention 1 → Arm 1 (pulmonary rehabilitation group).
Other interventionArm1: pulmonary rehabilitation group participants will perform physical therapy program and receive standardized pulmonary rehabilitation. Intervention(s): pulmonary rehabiliation program
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: Arm 1Experimental treatment 1 intervention
Group B: Arm 2Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
Exercise tolerance
It measures functional capacity and exercise tolerance and it measured by 6 minutes walk test usually participants walk in 30 meters distance in the usual waling pace
Time frame
2 months (8 weeks)Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: